NIPH Clinical Trials Search

UMIN ID: C000000046

Registered date:06/08/2005

A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedSymptomatic intrapelvic malignant tumor
Date of first enrollment2005/06/01
Target sample size33
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Radiofrequency ablation needle is percutaneouly inserted into the intrapelvic malignant tumor and radiofrequency ablation is performed.


Primary OutcomeAdverse events
Secondary OutcomeImprovement of symptom measured by Visual Analogue Scale at 1 week after the procedure.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) No symptom or VAS of less than 3. 2) Cardiac pacemaker. 3) Artery or nerve along the puncture route. 4) Lesion or target area adjacent to critical organs. 5) Infection in the target area. 6) Pregnancy.

Related Information


public contact
Name Yasuaki Arai
Address 5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan Japan
Telephone 03-3542-2511
Affiliation JIVROSG, Coordinating Office Division of Diagnostic Radiology, National Cancer Center Hospital
scientific contact
Name Hiroshi Anai
Address 804, Shijo-cho, Kashihara 634-8558, Japan, Japan
Telephone 0744-29-8900
Affiliation Nara Medical University Department of Radiology